Key Highlights
- Analog Devices posted its first-ever $4 billion quarter, with fiscal third-quarter Revenue of $4.021 billion, up 40% year over year.
- onsemi's second-quarter revenue reached $1.60 billion, up about 9%, as it retools around AI power and physical AI.
- Senseonics' implantable glucose sensor drove second-quarter revenue up roughly 120% to $14.5 million.
- SEALSQ, the most speculative name here, grew first-half revenue 131% to $11.2 million on post-quantum secure-chip demand.
Walk down the electronic-technology aisle of the Nasdaq Composite in September 2026 and the range of outcomes is striking. Analog Devices (NASDAQ:ADI) just booked its first $4 billion quarter. Onsemi (NASDAQ:ON) is retooling around AI power and physical AI through a major acquisition. Gilat (NASDAQ:GILT) is buying its way deeper into US defense. Senseonics (NASDAQ:SENS) is scaling an implantable glucose sensor. SEALSQ (NASDAQ:LAES) is spending heavily to build a post-quantum chip Franchise that is still tiny in revenue.
They rarely trade as a bloc. Some ride AI data-center demand; others depend on medical adoption, government budgets or a security transition that has barely begun. Every figure below traces to a cited company release or reputable source.
The Backdrop: AI Pulls, Autos Lag, Rates Ease Slowly
Two forces dominate the semiconductor tape this year. The first is AI infrastructure, which has become the clearest Demand engine: both Analog Devices and onsemi called out AI data-center revenue as their fastest-growing line. The second is the still-uneven recovery in the traditional cyclical end markets, automotive and broad industrial, where inventory corrections lingered longer than bulls hoped.
The macro overlay is a Federal Reserve that has moved cautiously. After a run of cuts into late 2025, the Central Bank held rates steady through mid-2026 and its own projections pointed to roughly a single cut for the year, according to Fed communications and contemporaneous coverage. Lower-for-longer financing costs matter unevenly here: cash-generative large caps shrug them off, while pre-profit names such as SEALSQ and Senseonics live and die by capital-market access. That divergence, profitable scale versus story-stage growth, is the real fault line running through these five tickers, and it frames how to read each one.
Analog Devices (NASDAQ:ADI): The Broad-Based Bellwether Clears $4 Billion
Analog Devices (NASDAQ:ADI) is the anchor of this group and, arguably, of the analog sector. For its fiscal third quarter ended August 1, 2026, reported August 19, ADI posted revenue of $4.021 billion, up 40% year over year, its first four-billion-dollar quarter. GAAP diluted EPS was $2.74 and adjusted EPS $3.45, with adjusted gross Margin of 72.5%.
The mix tells the story. Industrial, ADI's largest segment, rose 53% to $1.972 billion; communications jumped 84% to $655 million on data-center strength; automotive grew 16% and consumer 6%. Management guided fiscal Q4 revenue to roughly $4.3 billion, plus or minus $100 million, and declared a $1.10 quarterly dividend.
Analytically, ADI's appeal is breadth: it is not a single-theme bet, and the reacceleration across industrial and communications suggests the analog cycle has genuinely turned rather than merely bounced. The company also returned $1.7 billion to shareholders in the quarter through dividends and buybacks, underscoring the cash-generative profile that lets it invest through downturns. The forecast risk is that the year-over-year growth rates flatter an easy comparison against a weak 2025; investors should watch whether sequential momentum, not just the optics of the comparison, holds into the new fiscal year. CEO Vincent Roche framed the quarter as "broad-based demand."
onsemi (NASDAQ:ON): Reshaping Around AI Power and Physical AI
Onsemi (NASDAQ:ON) is the power-and-sensing counterweight to ADI's precision analog. Its second quarter of 2026, reported August 3, brought revenue of $1.60 billion, up about 9% year over year, with GAAP EPS of $0.56 and non-GAAP EPS of $0.74 on a non-GAAP gross margin of 39.3%. Automotive revenue was $781 million and industrial $423 million, steady, not spectacular, reflecting the still-soft auto cycle.
The forward story is AI power. CEO Hassane El-Khoury said the company now expects AI data-center revenue to more than double in 2026, and onsemi introduced its GaNEXUS gallium-nitride portfolio to round out an AI power stack alongside its silicon-carbide franchise. The larger move is strategic: onsemi announced plans to acquire Synaptics to push into "physical AI," a deal several outlets, including Manufacturing Dive, valued at roughly $7 billion.
For Q3, onsemi guided to $1.65–$1.75 billion in revenue and non-GAAP EPS of $0.81–$0.93. The analytical tension is clear: a promising AI-power narrative and margin recovery, set against automotive softness and the integration risk of a large acquisition. Execution on both is what to watch.
Gilat Satellite Networks (NASDAQ:GILT): Betting the Growth Story on Defense
Gilat Satellite Networks (NASDAQ:GILT) widens the aperture from chips to the electronic systems that move data across the sky. Its second-quarter 2026 results, reported August 5, showed revenue of $122.7 million, up 17% year over year, with GAAP Net Income of $8.1 million ($0.10 diluted EPS) and non-GAAP net income of $15.6 million ($0.20). Adjusted EBITDA rose 31% to $15.4 million. By segment, commercial contributed $83.0 million, defense $22.5 million and the Peru operations $17.2 million.
The catalyst is defense. In June 2026 Gilat agreed to acquire Comtech's satellite and space communications Business for $157.5 million, a deal it says would lift pro forma annual revenue above $700 million and deepen its exposure to US defense demand, with closing targeted around year-end. CEO Adi Sfadia has framed it as transformational.
Gilat reaffirmed full-year 2026 guidance of $500–$520 million in revenue and $61–$66 million in adjusted EBITDA. The bull case is a profitable, cash-generative comms operator adding scale in a well-funded end market; the risks are integration, regulatory approval and the cash demands the deal implies, the very concerns that pressured the shares on results day, per reporting.
Senseonics (NASDAQ:SENS): Where "Electronic Technology" Meets the Body
Senseonics Holdings (NASDAQ:SENS) is the medical-device sensor entry, and a reminder that electronic technology increasingly lives inside patients. Its Eversense 365 implantable continuous glucose monitor drove second-quarter 2026 revenue, reported August 6, to $14.5 million, up roughly 120% year over year, with US revenue of $12.6 million (up about 150%). Gross margin was near 59%, above the company's guided range.
Adoption is the headline: management cited its highest quarterly shipment Volume ever and active prescribers up roughly 130% year over year. Senseonics raised full-year 2026 revenue guidance to $62–$66 million. CEO Tim Goodnow pointed to development programs, including Gemini and Freedom, as the next legs of the roadmap.
The counterweight is profitability and funding. The company reported a net loss of $36.7 million (a $0.63 loss per share) against cash and restricted cash of $143.0 million. This is a growth-stage story: the sensor technology is differentiated, but the Investment thesis rests on whether rapid revenue growth eventually converges with a path to sustainable cash generation. For a pre-profit name, capital-market conditions and Burn Rate belong at the top of the watch list.
SEALSQ (NASDAQ:LAES): Spending Big to Own the Post-Quantum Transition
SEALSQ Corp (NASDAQ:LAES) is the most speculative name here, a secure-chip company positioning for the shift to post-quantum cryptography. For the first half of 2026, reported September 11, SEALSQ posted revenue of $11.2 million, up 131% year over year, helped by secure-element demand and the consolidation of IC'Alps. Gross margin was around 48%.
But the losses widened as the company invests ahead of the opportunity: an operating loss of $32.2 million and a net loss of $27.8 million. Crucially, its Balance Sheet is unusually deep for its size, with cash, equivalents and restricted cash of $486.1 million as of June 30. That war chest is the whole point, it funds the QS7001 post-quantum chip, advancing through NIST entropy-source validation and Common Criteria testing, and the QVault TPM.
SEALSQ reaffirmed 2026 revenue guidance of $27–$36 million and pointed to a business pipeline exceeding $225 million through 2029. The analytical read: this is a bet on a real long-term transition, quantum-resistant security, where revenue today is a rounding error next to the ambition. The risk is straightforward. Pipeline is not revenue, standards timelines slip, and heavy spending against a small base leaves little room for error.
What Investors Should Watch
The near-term signposts differ by name. For ADI and onsemi, watch whether AI data-center strength keeps offsetting soft automotive and industrial demand, and whether sequential, not just year-over-year, growth holds; for onsemi specifically, watch Synaptics integration and gallium-nitride traction. For Gilat, the Comtech close, regulatory approvals and defense-backlog conversion are the swing factors. For Senseonics, track prescriber growth, Eversense adoption and the trajectory of cash burn. For SEALSQ, the tells are QS7001 certification milestones and whether pipeline converts into booked orders.
Chips, Satellites and a Sensor Inside the Body
Grouped this way, these five tickers are not a single trade. ADI and onsemi are profitable, scaled and increasingly levered to AI power and precision analog; Gilat is a cash-generative comms operator reshaping around defense; Senseonics and SEALSQ are story-stage growth names whose futures hinge on adoption curves and funding. The theme investors keep underestimating is the common thread: "semiconductors and electronic technology" now spans chips, satellites, implants and cryptography. The Nasdaq Composite reflects all of it.






Please wait processing your request...